Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2017
As of Sep 30, 2017
Q2 FY2017
As of Jul 1, 2017
Q1 FY2017
As of Apr 1, 2017
Q4 FY2016
As of Dec 31, 2016
Q3 FY2016
As of Sep 30, 2016
Q2 FY2016
As of Jun 30, 2016
Q1 FY2016
As of Mar 31, 2016
Q4 FY2014
As of Dec 31, 2014
Assets
Current assets:
Cash and cash equivalents
Successor
Total cash and cash equivalents
Accounts receivable, net of allowances of $12,849 and $9,261, respectively
Successor
Total accounts receivable, net of allowances of $12,849 and $9,261, respectively
Inventories
Successor
Total inventories
Net deferred tax assets-current portion
Other current assets
Successor
Total other current assets
Prepaid expenses and other current assets
Successor
Total current assets
Property, plant and equipment, net
Successor
Total property, plant and equipment, net
Other assets:
Goodwill
Successor
Total goodwill
Intangible assets, net
Successor
Total intangible assets, net
Net deferred tax assets-long term
Successor
Total other assets
Successor
Total assets
Liabilities and shareholders' equity
Current liabilities:
Accounts payable
Successor
Total accounts payable
Accrued liabilities
Successor
Total accrued liabilities
Accounts payable and accrued expenses
Senior term loan- current portion
Successor
Total senior term loan- current portion
Founder contingent consideration
Successor
Total founder contingent consideration
Tax receivable obligation- current portion
Successor
Total tax receivable obligation- current portion
Notes payable, net- current portion
Other current liabilities
Successor
Total other current liabilities
Successor
Total current liabilities
Long-term liabilities:
Senior term loan, net
Successor
Total senior term loan, net
Revolving credit facility, net
Successor
Total revolving credit facility, net
Notes payable, net
Successor
Total notes payable, net
Founder contingent consideration
Net deferred tax liabilities
Successor
Total net deferred tax liabilities
Tax receivable obligation
Successor
Total tax receivable obligation
Other long-term liabilities
Successor
Total other long-term liabilities
Successor
Total long-term liabilities
Shareholders' Equity:
Common stock, $0.0001 par value, 375,000,000 shares authorized at September 30, 2017 and December 31, 2016 and 76,744,340 and 76,786,000 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively
Successor
Total common stock, $0.0001 par value, 375,000,000 shares authorized at September 30, 2017 and December 31, 2016 and 76,744,340 and 76,786,000 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively
Additional paid-in capital
Successor
Total additional paid-in capital
Common stock held in treasury, at par, 1,555,007 and 2,948,995 shares at September 30, 2017 and December 31, 2016, respectively
Successor
Total common stock held in treasury, at par, 1,555,007 and 2,948,995 shares at September 30, 2017 and December 31, 2016, respectively
Retained earnings
Successor
Total retained earnings
Accumulated other comprehensive income (loss)
Successor
Total shareholders' equity
Successor
Total liabilities and shareholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support